Instem, a global leader in SaaS solutions for life sciences R&D, today announced a 5-year extension of its Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA). (Q)SAR models must be continually updated and validated to remain relevant as new compound classes and chemistries advance through pharmaceutical drug development. At the same […]
BOZEMAN, Mont. — Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and precision medicine, is proud to announce a strategic agreement with the Austrian public medical genetics labs. The agreement aims to enhance the genomic capabilities of multiple laboratories within the country, supporting critical advancements in cancer and hereditary disease diagnostics. […]
Partnership combines Inocras’s clinical grade cancer diagnostics and analytics solutions with NDS’s cloud and secure data environment infrastructure SAN DIEGO & SEOUL, South Korea — Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights, today announced a strategic partnership with NDS Corporation (NDS), a South Korean […]
Genomenon’s Curation and Global Distribution of Variant Data Reduces Barriers to Genetic Diagnosis ANN ARBOR, Mich. – Genomenon today announced a strategic sponsorship from Amicus Therapeutics to accelerate awareness, diagnosis, and research for Fabry disease. Through this collaboration, Genomenon produced literature-derived real-world evidence by applying fit-for-purpose AI and expert review to curate and classify variants in […]
Zurich – BC Platforms, a global leader in healthcare data, technology, and analytics today announced enhancements to BC Mosaic, its AI-powered trusted research environment (TRE), now available on AWS Marketplace. Featuring an all-new, intuitive user interface, BC Mosaic enables secure, compliant analysis of complex clinical, real-world, and multi-omics data within a single trusted research environment. Designed to make trusted […]
Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money. RADNOR, Pa. — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based pharmacokinetic (PBPK) modeling predictions accepted by the U.S. FDA in lieu of clinical studies to support the new drug application […]
SOMERVILLE, Mass. — Matterworks, Inc., a frontier AI company providing predictive biology tools that accelerate discovery, development and manufacturing across life science applications, announced that Paul Stone has joined the company as Chief Financial Officer and Head of Corporate Development. Mr. Stone is a life sciences executive with over twenty-eight years of experience and leadership […]
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the extension of two separate research collaborations with the U.S. Food and Drug Administration (FDA) and the National Institute of Environmental Health Sciences (NIEHS). The extended projects support ongoing federal […]
Patient catchment now includes 187 million+ patient lives, enables advanced analytics and AI modeling for diverse, under-represented patient populations Zurich – BC Platforms, a global leader in healthcare data, technology, and analytics today announced a strategic partnership with OmicsBank, a healthcare AI-ready data infrastructure company specializing in enabling access to large-scale, research-ready longitudinal and multi-modal real-world […]
Adds Private Equity and Operational Experience to Help Scale iOrganBio’s Operations CHAPEL HILL, N.C. — iOrganBio, an innovator in intelligent cell manufacturing redefining how human cells are engineered and reliably produced at scale for research and therapy, including as New Approach Methodologies (NAMs) in alignment with FDA direction, today announced the appointment of Karol Jarzabek […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
